Stem cell gene therapy (Woodridul Huebrain)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameStem cell gene therapy (Woodridul Huebrain)
Drug Alias Name干细胞基因疗法(Woodridul Huebrain)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionBone modulatorsStem cells modulators
TargetsNot applicable
Therapy Area/IndicationsSpinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWoodridul Huebrain
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWoodridul Huebrain
Active IndicationsN/A
Inactive IndicationsSpinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A